Home \ Outreach \


Clinical study of a trial on VLP vaccine for bluetongue virus serotypes 1 & 1+4 in sheep

Oral communication in VIII Congreso de Ciencias Veterinarias y Biomedicas

April 27th, 2009

Perez de Diego AC., del Carmen P., Carvajal J. and Sanchez-Vizcaino JM.

Bluetongue Virus disease is an infectous disease submitted to a sanitary control composed by
several measures of prevention, and one of these measures is the vaccination of the sensible
species. In the development of vaccines opposite to this disease, a new trend is the production
of polyvalent vaccines by VLP`s technology (virus like particles). This work has had as aim to
value by clinical survey, 2 VLP vaccines, for serotypes 1 and 1+4. The results confirm the
lack of fever, clinical signs and pathologic injuries in vaccinated animals opposite to control
animals, which indicates that these new vaccines protect for the appearance of clinical signs




Participants:

Universidad ComplutenseServicio de Inmunología Viral y Medicina Preventiva (SUAT). Centro de Vigilancia Sanitaria Veterinaria (VISAVET). Universidad Complutense (UCM).

Universidad ComplutenseDepartamento de Sanidad Animal. Facultad de Veterinaria. Universidad Complutense (UCM).


Go to publication web
Publication: Clinical study of a trial on VLP vaccine for bluetongue virus serotypes 1 & 1+4 in sheep





publiDB

VIII Congreso de Ciencias Veterinarias y Biomedicas



TITLE: Seguimiento clinico del ensayo de una vacuna VLP para los serotipos 1 y 1+4 de la lengua azul en ganado ovino


TYPE: Oral communication


AUTHORS: Perez de Diego AC., del Carmen P., Carvajal J. and Sanchez-Vizcaino JM.


VISAVET PARTICIPANTS


José Manuel Sánchez-Vizcaíno Rodríguez

DATE: April 27th, 2009


CITE THIS COMMUNICATION:

Perez de Diego AC., del Carmen P., Carvajal J. and Sanchez-Vizcaino JM. Clinical study of a trial on VLP vaccine for bluetongue virus serotypes 1 & 1+4 in sheep. VIII Congreso de Ciencias Veterinarias y Biomedicas, Facultad de Veterinaria. UCM, April 27th, 2009. (Oral communication)


UNITS: